Indicators of immune status in the blood of patients depending on the stage of atrophic gastritis according to the OLGA system
- Authors: Tsukanov V.V.1, Vasyutin A.V1, Tonkikh Y.L1, Smirnova O.V1, Sinyakov A.A1, Elmanova N.G1
-
Affiliations:
- Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"
- Issue: Vol 27, No 2 (2020)
- Pages: 31-36
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312502
- DOI: https://doi.org/10.18565/pharmateca.2020.2.31-36
- ID: 312502
Cite item
Abstract
Keywords
Full Text
About the authors
Vladislav V. Tsukanov
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"
Email: gastro@impn.ru
Dr. Sci. (Med.), Professor, Head of the Clinical Department of Pathology of Digestive System in Adults and Children, Scientific Research Institute of Medical Problems of the North Krasnoyarsk, Russia
A. V Vasyutin
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
Yu. L Tonkikh
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
O. V Smirnova
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
A. A Sinyakov
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
N. G Elmanova
Federal Research Center “Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences"Research Institute of Medical Problems of the North Krasnoyarsk, Russia
References
- Gupta S., Tao L., Murphy J.D., et ai. Race/ Ethnicity-, Socioeconomic Status-, and Anatomic Subsite-Specific Risks for Gastric Cancer Gastroenterology. 2019;156(1):59-62. doi: 10.1053/j.gastro.2018.09.045.
- Venerito M., Link A., Rokkas T., Maifertheiner P Review: Gastric cancer-Ciinicai aspects. Helicobacter. 2019;24(1):e12643. Doi: 10.1111/ hei.12643.
- Piiieron S., Sarfati D., Janssen-Heijnen M., et ai. Giobai cancer incidence in oider aduits, 2012 and 2035: A popuiation-based study Int J Cancer. 2019;144(1):49-58. doi: 10.1002/ijc.31664.
- Sugano K. Effect of Heiicobacter pyiori eradication on the incidence of gastric cancer: a systematic review and meta-anaiysis. Gastric Cancer. 2019;22(3):435-45. doi: 10.1007/s10120-018-0876-0.
- Kaji K., Hashiba A., Uotani C., et al. Grading of Atrophic Gastritis is Usefui for Risk Stratification in Endoscopic Screening for Gastric Cancer. Am J Gastroenteroi. 2019;114(1):71-9. doi: 10.1038/s41395-018-0259-5.
- Rugge M., Sacchi D., Graham D.Y., Genta R.M. Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut. 2019 Jun 11. Doi: 10.1136/ gutjnl-2019-319107.
- Rugge M., Sugano K., Scarpignato C., et al. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. Helicobacter 2019;24(2):e12571. doi: 10.1111/hel.12571.
- Kuhns M.S., Badgandi H.B. Piecing together the family portrait of TCR-CD3 complexes. Immunol Rev. 2012;250(1):120-43. Doi: 10.1111/ imr. 12000.
- Zhu J., Paul W.E. Heterogeneity and plasticity of T helper cells. Cell Res. 2010;20(1):4-12. doi: 10.1038/cr.2009.138.
- Kikete S., Chu X., Wang L., Bian Y Endogenous and tumour-derived microRNAs regulate crosspresentation in dendritic cells and consequently cytotoxic T cell function. Cytotechnology. 2016;68(6):2223-33. doi: 10.1007/s10616-016-9975-0.
- Sharma P, Kumar P, Sharma R. Natural Killer Cells - Their Role in Tumour Immunosurveillance. J Clin Diagn Res. 2017;11(8):BE01-BE05. doi: 10.7860/JCDR/2017/26748.10469.
- Hoffman W., Lakkis F.G., Cells B. Antibodies, and More. Clin J Am Soc Nephrol. 2016;11(1):137-54. doi: 10.2215/CJN.09430915.
- Агеева Е.С., Штыгашева О.В., Рязанцева Н.В., Цуканов В.В. Молекулярно-генетические факторы, влияющие на исход инфицирования Heiicobacter pyiori у жителей Республики Хакасия. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2010;20(4):16-21.
- McMahon B.J., Bruce M.G., Koch A., et ai. The diagnosis and treatment of Heiicobacter pyiori infection in Arctic regions with a high prevaience of infection: Expert Commentary Epidemioi Infect. 2016;144(2):225-33. Doi: 10.1017/ S0950268815001181.
- Агеева Е.С., Штыгашева О.В., Цуканов В.В., Рязанцева Н.В. Иммунологические особенности течения гастродуоденальной патологии у жителей Хакасии. Иммунология. 2009;30(3):162-64.
- Cappeiiesso R., Fassan M., Hanspeter E., et ai. HER2 status in gastroesophageai cancer: a tissue microarray study of 1040 cases. Hum Pathoi. 2015;46(5):665-72. Doi: 10.1016/j. humpath.2015.02.007.
- Цуканов В.В., Васютин А.В., Тонких Ю.Л. и др. Иммунологические аспекты патогенеза атрофического гастрита. Врач. 2019;30(5):47-50. doi: 10.29296/25877305-2019-05-08.
- Buommino E., Donnarumma G., Manente L., et ai. The Heiicobacter pyiori protein HspB interferes with Nrf2/Keap1 pathway aitering the antioxidant response of Ags ceiis. Heiicobacter. 2012;17(6):417-25. doi: 10.1111/j.1523-53 78.2012.00973.x.
- Цуканов В.В. Смирнова О.В., Каспаров Э.В. и др. Изменения показателей прооксидантной и антиоксидантной систем в плазме крови у муж чин при атрофическом гастрите и раке желудка. Терапевтический архив. 2018;90(2):24-7. doi: 10.26442/terarkh201890224-27.
- Pimentei-Nunes P., Libânio D., Marcos-Pinto R., et ai. Management of epitheiiai precancerous conditions and iesions in the stomach (MAPS II): European Society of Gastrointestinai Endoscopy (ESGE), European Heiicobacter and Microbiota Study Group (EHMSG), European Society of Pathoiogy (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideiine update 2019. Endoscopy. 2019;51(4):365-88.
- Sugano K., Tack J., Kuipers E.J., et al. Kyoto giobai consensus report on Heiicobacter pyiori gastritis. Gut. 2015;64(9):1353-67. Doi: 10.1136/ gutjni-2015-309252.
- Maifertheiner P., Megraud F., O'Morain C.A., et al. Management of Heiicobacter pyiori infection-the Maastricht V/Fiorence Consensus Report. Gut. 2017;66(1):6-30. Doi: 10.1136/ gutjni-2016-312288.
- Бордин Д.С., Янова О.Б., Абдулхаков Р.А. и др. Европейский регистр Heiicobacter pyiori (протокол Hp-EuReg): первые результаты российских центров. Терапевтический архив. 2016;88(2): 33-8. doi: 10.17116/terarkh201688233-38.